Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu Xu

Showing results (671-680 of 672) with videos related to

Pageof 68
Sort By:
You have reached the last page of results.This site can display upto 672 results.
The Lancet. Respiratory Medicine|August 30, 2025
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational studyOriol Sibila, Jamie Stobo, Lidia Perea, et al.
The Lancet. Respiratory Medicine|May 19, 2026
Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registriesRebecca C Hull, Yang Liu, Zu Cao, et al.
Pageof 68

Showing results (671-680 of 672) with videos related to

Sort By:
Pageof 68
You have reached the last page of results.This site can display upto 672 results.
The Lancet. Respiratory Medicine|August 30, 2025
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational studyOriol Sibila, Jamie Stobo, Lidia Perea, et al.
The Lancet. Respiratory Medicine|May 19, 2026
Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registriesRebecca C Hull, Yang Liu, Zu Cao, et al.
Pageof 68